Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Conditions:   Angiofibroma of Face;   Tuberous Sclerosis Interventions:   Drug: Sirolimus 0.2%;   Drug: Sirolimus 0.4%;   Drug: Placebo ointment Sponsor:   Aucta Pharmaceuticals, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials